# Sex Hormones and Orthostatic Tolerance

> **NCT01153581** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 109 (actual)

## Conditions studied

- Orthostatic Intolerance

## Interventions

- **DRUG:** Ganirelix acetate
- **DRUG:** 17β-Oestradiol
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT01153581
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2012-12
- **Final completion:** 2013-05
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2018-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01153581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01153581, "Sex Hormones and Orthostatic Tolerance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01153581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*